Sir,
The possible role of genetic factors in the pathogenesis of microangiopathy was recently reviewed in Diabetologia by Barbosa and Saner [1] who pointed out that most studies on Type 1 diabetic patients tend to show an increased frequency of HLA-B~5 or -DR4 in association with severe or proliferative retinopathy. However,, as discussed by these authors [1] , one Icelandic study [2] has suggested that HLA-Ba5 positive patients might be less prone to develop retinopathy. This issue may be further elucidated by a recent report by Hoogwerf et al. [3] which demonstrates a decline of C-peptide secretion in Type 1 diabetic patients with increased duration of the disease. In addition, the stimulated C peptide response was found to be less marked in patients who were younger than 10 years old at the onset of diabetes. Furthermore, HLA-DR4 positive subjects had higher mean C-peptide values than -DR4 negative patients, irrespective of the duration of the disease. The authors concluded that DR4 positive patients might be blessed by a better preservation of r-cell function and discussed that this might further glycaemic control, and hence delay or postpone microvascular complications in the diabetic patient [4] . A previous study of the Icelandic Type 1 diabetic population [5] has demonstrated that a subgroup of patients without retinopathy after a diabetes duration of 20 years or more required significantly less insulin than those with retinopathy after a comparable duration of the disease. The mean (+ SD) age at diagnosis of diabetes in the retinopathy-free subjects was 30 + 4 years and 70% were females. Late onset of diabetes and female preponderance are believed to characterize "autoimmune" diabetes [6] . In a study of Type 1 diabetic patients with thyroid disorders in Iceland [7] the age at the onset of diabetes was 38__ 1 years and 80% were females. They tended to require less than average insulin doses, eye and kidney complications were reactively rare, and, particularly, a higher frequency was found for HLA-Ba5 than -B8 (relative risks 4.2 and 2.3 respectively).
Whether HLA-types are directly related to the age at onset of diabetes is presently controversial. HLA-DR4 has been reported to be significantly increased in Type 1 diabetes with age of onset after 40 years [8] . Other authors were unable to find such an association in analysing different subgroups according to their age at onset up to the age at onset of 25 years [9] . Likewise, the frequency of HLA-B~5 is similar in patients diagnosed 0-19 years old compared to those with an age at onset of above 30years in the Icelandic diabetic patients (unpublished).
In conclusion, HLA-DR4, and probably HLA-B15, because of the strong linkage disequilibrium between these two, appear to be related to better preservation of residual r-cell function. This is demonstrated 709 by a greater C-peptide response in HLA-DR4 positive Type 1 diabetes patients. This may result in better glycaemic control in these patients and retard the development of long-term microvascular complications. These data may thus be compatible with the previous finding of less retinopathy in HLA-B15 positive Type 1 diabetic patients in Iceland.
Yours sincerely R. Danielsen
